The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

BOVALTO Respi 4 suspension for injection

Boehringer Ingelheim Vetmedica GmbHVPA10454/029/002

Main Information

Trade NameBOVALTO Respi 4 suspension for injection
Active SubstancesInactivated bovine respiratory syncytial virus, strain bio-24
Inactivated bovine parainfluenza 3 virus, strain bio-23
Inactivated mannheimia haemolytica serotype a1 strain dsm 5283
Inactivated bovine viral diarrhoea virus, strain bio-25
Dosage FormSuspension for injection
Licence HolderBoehringer Ingelheim Vetmedica GmbH
Licence NumberVPA10454/029/002

Group Information

ATC CodeQI02AL Inactivated viral and inactivated bacterial vaccines
Therapeutic ClassImmunological - Inactivated Vaccine


License statusAuthorised
Licence Issued26/02/2016
Legal StatusPOM (E): Prescription Only Exempt as defined in relevant national legislation


Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsNo document available

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back